EP3334432
CERDULATINIB FOR TREATING MYELOMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.8.2016EP published:
23.2.2022EP application number:
16835995.8
EPO information:
European Patent Register
Max expiry date:
11.8.2036
Title in English:
CERDULATINIB FOR TREATING MYELOMALanguage of the patent:
English
Timeline
Today
12.8.2016EP application
23.2.2022EP Publication
Owner
Name:
Portola Pharmaceuticals, Inc.Address:
270 East Grand Avenue Suite 22, South San Francisco, California 94080, US
Inventor
Name:
COFFEY, GregoryAddress:
South San Francisco, California 94080, US
Name:
FENG, JiajiaAddress:
South San Francisco, California 94080, US
Priority
Number:
201562204400 PDate:
12.8.2015Country:
US
Number:
201662342711 PDate:
27.5.2016Country:
US
Classification
Categories:
A61K 31/506, A61K 31/551, C07D 279/12, A61K 45/06, A61P 35/02